Amneal Pharmaceuticals (AMRX) Income from Non-Controlling Interests (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted Income from Non-Controlling Interests of $11.95 million for Q2 2026, down 9.4% from $13.19 million a year earlier and down 24.1% from the prior quarter.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) Income from Non-Controlling Interests (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income from Non-Controlling Interests at Amneal Pharmaceuticals was $57.96 million, up 21.1% year-over-year; for FY2025, it was $55.88 million, up 29.9% from FY2024.
- In prior years, Amneal Pharmaceuticals' Income from Non-Controlling Interests was $43.01 million in FY2024 (+21.9%), $35.27 million in FY2023, -$125.24 million in FY2022 and $9.55 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Income from Non-Controlling Interests since Q4 2024.
- On a year-over-year basis, Income from Non-Controlling Interests increased in six of the last eight quarters, with growth averaging 26.2%.
- The strongest year-over-year quarter for Income from Non-Controlling Interests in the past five years was Q4 2024, with growth of 94.9%; the weakest was Q2 2024, with a decline of 39.2%.
- According to Business Quant data, Income from Non-Controlling Interests for the three prior quarters was $15.74 million (Q1 2026), $14.5 million (Q4 2025) and $15.76 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Amneal Pharmaceuticals | 6.48 Bn | 5.76 Bn | 334.51 Mn | 11.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.95 Mn |
| Mar 31, 2026 | 15.74 Mn |
| Dec 31, 2025 | 14.50 Mn |
| Sep 30, 2025 | 15.76 Mn |
| Jun 30, 2025 | 13.19 Mn |
| Mar 31, 2025 | 12.42 Mn |
| Dec 31, 2024 | 10.34 Mn |
| Sep 30, 2024 | 11.91 Mn |
| Jun 30, 2024 | 10.79 Mn |
| Mar 31, 2024 | 9.97 Mn |
| Dec 31, 2023 | 5.31 Mn |
| Sep 30, 2023 | 15.35 Mn |
| Jun 30, 2023 | 17.77 Mn |
| Mar 31, 2023 | -3.15 Mn |
| Dec 31, 2022 | -1.53 Mn |
| Sep 30, 2022 | 299,000.00 |
| Jun 30, 2022 | -119.27 Mn |
| Mar 31, 2022 | -4.74 Mn |
| Dec 31, 2021 | -14.08 Mn |
| Sep 30, 2021 | -1.86 Mn |
API Access
Amneal Pharmaceuticals Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=AMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();